INX-315
Product Specifications
CAS Number
2745060-92-6
SKU
C01910-5mg
Target
CDK
Applications
Cell Cycle
Additionnal Information
INX-315 is an orally active and selective inhibitor of CDK2 that induces cell cycle arrest in the G1 phase. It exhibits an IC50 value of 2.3 nM in intracellular NanoBRET assay, respectively. It displays a 50-fold increased CDK2 selectivity compared to CDK1. INX-315 decreases the phosphorylation of CDK2 substrates and suppresses tumor growth in xenograft mouse models in a dose-dependent manner.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-310370 500 mg
3- (tert-Butyl) -5- (4-nitrophenyl) -1,2,4-oxadiazole
Sign In for Pricing
View Details